Can-C Eye Cataract Eye N-Acetylcarnosine Drops – 5ml (2 x 1 Pack)

Key Benefits.

Reduces the occurrence and the development of senile cataract.
Assist to lower the intraocular pressure associated with glaucoma.
Beneficial for contact lens disorders.
Helps those suffering from presbyopia.
Treat corneal disorders.
Combat eyestrain.
Ease computer vision syndrome.
End the discomfort of ocular inflammation.
Restore normal sight to those inflicted with blurred vision.
Alleviate dry eye syndrome.
Success in the fight against retinal diseases.
Treatment of vitreous opacities and lesions.
Improve the function of the aging eye.

Can-C eye drops are one of the latest anti-ageing breakthroughs and contain a special form of Carnosine, called N-acetylcarnosine, a natural antioxidant, that has achieved remarkable results in clinical trials. Dr Babizhayev, who headed the Russian research team (Innovative Vision Products – IVP) that developed this ground breaking treatment, has stated that the maximum obtainable results are usually achieved in a 3 to 5 month period, however there are often noticeable benefits within only 1 month. Marios Kyriazis, M.D. has written a booklet on the subject. In it he states that the research highlights that quality and formula are essential to both efficacy and long-term safety. To ensure that you are purchasing an officially approved and tested product, the packaging should clearly state that it is approved by IVP. Can-C is the world’s first N-acetylcarnosine eye-drop to meet the strict criteria laid down by IVP and is therefore officially approved by IVP. Can-C eye-drops are sold as an eye-lubricant, but are being used in parts of the world for other eye problems as well. They are safe to be used by most people, including those with cataracts. Initially, instil two drops into one or both eyes twice a day – there is no benefit in exceeding this dose. Once the effects are being felt (usually after 4-6 months), one drop twice a day is usually a suitable on-going regime. It is recommended that occasional use of N-acetylcarnosine eye-drops continue even after the reduction/reversal of symptoms to prevent any re-occurrence.